SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-076026
Filing Date
2020-03-17
Accepted
2020-03-17 16:25:05
Documents
7
Period of Report
2020-03-17

Document Format Files

Seq Description Document Type Size
1 6-K d898979d6k.htm 6-K 13711
2 EX-99.1 d898979dex991.htm EX-99.1 14233
3 EX-99.2 d898979dex992.htm EX-99.2 62645
4 GRAPHIC g898979g0317091522305.jpg GRAPHIC 2906
5 GRAPHIC g898979g70n29.jpg GRAPHIC 3406
6 GRAPHIC g898979g76l27.jpg GRAPHIC 5177
7 GRAPHIC g898979snap0004.jpg GRAPHIC 4543
  Complete submission text file 0001193125-20-076026.txt   114421
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 20721318
SIC: 2836 Biological Products, (No Diagnostic Substances)